N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
about
Dynamic changes in cortical NADH fluorescence and direct current potential in rat focal ischemia: relationship between propagation of recurrent depolarization and growth of the ischemic core.Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.Modulation of the N-methyl-D-aspartate channel by extracellular H+.Management of acute ischemic stroke. An update for primary care physicians.CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activityCombined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord.Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic strokeWhat have drugs to offer the patient with acute stroke?Role of cannabinoids and endocannabinoids in cerebral ischemia.Acute stroke care--opportunities for limiting brain damage.Brain tissue responses to ischemia.Complicated migraine resulting in blindness due to bilateral retinal infarction.Using hormetic strategies to improve ischemic preconditioning and postconditioning against stroke.Commemorating John F. MacDonald and the Art of Being a Mentor.Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.Pharmacologic management of neonatal cerebral ischemia and hemorrhage: old and new directions.Neurochemical mechanisms in brain injury and treatment: a review.Toward the development of strategies to prevent ischemic neuronal injury. In vitro studies.Amelioration of ischemic brain damage by peritoneal dialysis.Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.Alterations in the production of 14CO2 and [14C]acetylcholine from [U-14C]glucose in brain subregions following transient forebrain ischemia in the rat.Chronic stress and lithium treatments alter hippocampal glutamate uptake and release in the rat and potentiate necrotic cellular death after oxygen and glucose deprivation.In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.Effects of MK-801 and NBQX on acute recovery of piglet cerebral metabolism after hypothermic circulatory arrest.Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat.Regional and temporal alterations in Ca2+/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia.The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression.Post-ischaemic alteration of excitatory amino acid transport sites in the gerbil hippocampus.Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.Neurodegenerative Effects Induced by Chronic Infusion of Quinolinic Acid in Rat Striatum and Hippocampus.Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.Dammarane derivatives protect cultured rat cortical cells from glutamate-induced neurotoxicity.Hypoxia-induced electrical changes in striatal neurons.Ketamine alters calcium and magnesium in brain tissue following experimental head trauma in rats.Recent advances in cerebrovascular disease
P2860
Q31036139-865A8CD0-B36F-4DFE-A78A-DA8BA190441EQ33723355-401299B4-5798-4EDB-98BF-08CF9B746FFDQ33755785-F4E69C51-D932-4E43-AFDD-04D7BC794F5FQ34185792-5FE504DE-7E26-4FA1-898E-2DD393F1C4F9Q35001085-DAB5A1EC-406C-40B0-BD05-70F2F90A2123Q35375651-3BCDDC39-F6C7-461C-82AE-D7B1E21E2CC2Q35674149-B140EEEC-5CB2-49E0-B067-1B671A683025Q35834042-1FFD22E7-0843-43C0-A79E-7BC644E88164Q36967863-58D114AA-E63C-49D7-BDB4-EBB5933CED8DQ37021804-7AEA92E9-A693-4B33-B9E1-8438513EAF68Q37270099-F6895967-D971-4FF6-B903-8FFC7267F2E7Q37295948-6BF7B3F6-2C4A-46AA-89E4-B1DB8B908F92Q38113219-4E1FA789-F93D-4C3B-9338-636045A0D855Q38917627-C8ECB97C-C5EB-4692-9BDA-C4EA8DB38EBAQ39472026-D2EE3231-139C-4D62-ADE2-DB9A0DB4117AQ40170517-13F9EF0A-7BAA-46AF-849D-FEBF587E5958Q40882064-CAC88FBB-8549-4BCB-A033-3BBEAE028E43Q41241794-3F6145DA-5A8B-4A92-979D-8C9725149DCCQ41643140-2DF1F6AD-9FAE-4154-BFD5-FC3569DF329FQ41905922-9E2EB66B-1A39-4BAE-9DA4-7C95F330311BQ41981482-8F692B3E-86FF-4F52-813E-BF78479A32C3Q42478410-1FACA7B9-4982-459C-A614-BB3776DF8064Q42482848-CBA92186-915B-4D98-9A10-EE550AE5088DQ45773755-C076959A-34C6-49C5-852B-CDA83C5E9FEEQ48198683-8634FE6D-5891-4192-AD13-EB10131DF73AQ48358481-C7B634E7-ABBD-40BD-A5C4-592D86F59B9CQ48491034-F0C65F97-5AA7-4CC0-B727-80AD5B56F51DQ48524692-61B23A51-3108-4421-B8EA-D31674EDC68BQ48534756-9AE63997-D694-4CFB-9E34-43DBBD755A9BQ48595418-D26C3CE8-FD35-4522-8F1B-6C79316E278EQ48640938-D02960B3-0CAB-4A81-9C0C-2C68C8F3BEB3Q48675911-87917576-E9A9-4AD5-BBFA-6083D1E3058DQ48699157-A1518569-4DCB-4F3E-8B3B-F0D6B92F28EBQ48769586-C3036A40-ECA6-4A03-A977-5C4629EBC531Q48936696-5BA7B509-291E-469A-A7B8-FE4B8D9D0F1FQ48986696-43627071-BBD5-4F91-8A0D-D6A2540F4DB9Q51590842-D3ACECDD-7B1C-4B9A-9A7A-5EA2CB35710FQ51650531-802A0785-CEB8-49A1-BF2D-EC2B820B9329Q57313187-34DC2DED-CCEF-4C36-8C4B-A54E99E2D10B
P2860
N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
@en
type
label
N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
@en
prefLabel
N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
@en
P2093
P2860
P356
P1433
P1476
N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
@en
P2093
P2860
P304
P356
10.1002/ANA.410250412
P577
1989-04-01T00:00:00Z